This paper is in the following e-collection/theme issue:

Telehealth and Telemonitoring (1671) Clinical Communication, Electronic Consultation and Telehealth (590) Infectious Diseases (non-STD/STI) (1575)

Published on in Vol 20, No 11 (2018): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9825, first published .
Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study

Authors of this article:

Chee Kin Lam1, 2 Author Orcid Image ;   Kara McGinnis Pilote1, 2 Author Orcid Image ;   Ashraful Haque2 Author Orcid Image ;   Joseph Burzynski2 Author Orcid Image ;   Christine Chuck2 Author Orcid Image ;   Michelle Macaraig2 Author Orcid Image
Article Authors Cited by (31) Tweetations (5) Metrics

Journals

  1. Harries A, Kumar A, Satyanarayana S, Thekkur P, Lin Y, Dlodlo R, Khogali M, Zachariah R. The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground. Tropical Medicine and Infectious Disease 2020;5(2):61 View
  2. Guo X, Yang Y, Takiff H, Zhu M, Ma J, Zhong T, Fan Y, Wang J, Liu S. A Comprehensive App That Improves Tuberculosis Treatment Management Through Video-Observed Therapy: Usability Study. JMIR mHealth and uHealth 2020;8(7):e17658 View
  3. Winchester N, Maldarelli F, Mejia Y, Dee N, Dewar R, Laidlaw E, Kuriakose S, Stoll P, Proschan M, Lane H, Pau A. Eight-day Inpatient Directly Observed Therapy for Antiretroviral Therapy (ART) Failure: A Tool For Preventing Unnecessary ART Changes and Optimizing Adherence Support. Clinical Infectious Diseases 2020;70(6):1222 View
  4. Garfein R, Doshi R. Synchronous and asynchronous video observed therapy (VOT) for tuberculosis treatment adherence monitoring and support. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2019;17:100098 View
  5. Donaghy E, Atherton H, Hammersley V, McNeilly H, Bikker A, Robbins L, Campbell J, McKinstry B. Acceptability, benefits, and challenges of video consulting: a qualitative study in primary care. British Journal of General Practice 2019;69(686):e586 View
  6. Creary S, Chisolm D, Stanek J, Neville K, Garg U, Hankins J, O'Brien S. Measuring hydroxyurea adherence by pharmacy and laboratory data compared with video observation in children with sickle cell disease. Pediatric Blood & Cancer 2020;67(8) View
  7. Lee Y, Raviglione M, Flahault A. Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review. Journal of Medical Internet Research 2020;22(2):e15727 View
  8. Manyazewal T, Woldeamanuel Y, Holland D, Fekadu A, Blumberg H, Marconi V. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial. Trials 2020;21(1) View
  9. Donahue M, Eberly M, Rajnik M. Tele-TB: Using TeleMedicine to Increase Access to Directly Observed Therapy for Latent Tuberculosis Infection. Military Medicine 2021;186(Supplement_1):25 View
  10. Leibowitz A, Satre D, Lu W, Weisner C, Corriveau C, Gizzi E, Sterling S. A Telemedicine Approach to Increase Treatment of Alcohol Use Disorder in Primary Care: A Pilot Feasibility Study. Journal of Addiction Medicine 2021;15(1):27 View
  11. Semitala F, Musinguzi A, Ssemata J, Welishe F, Nabunje J, Kadota J, Berger C, Katamba A, Kiwanuka N, Kamya M, Dowdy D, Cattamanchi A, Katahoire A. Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives. Implementation Science Communications 2021;2(1) View
  12. Ridho A, Alfian S, van Boven J, Levita J, Yalcin E, Le L, Alffenaar J, Hak E, Abdulah R, Pradipta I. Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials. Journal of Medical Internet Research 2022;24(2):e33062 View
  13. Creary S, Beeman C, Stanek J, King K, McGann P, O'Brien S, Liem R, Holl J, Badawy S. Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia. Pediatric Blood & Cancer 2022;69(6) View
  14. Jung Y, Schluger N. Advances in the diagnosis and treatment of latent tuberculosis infection. Current Opinion in Infectious Diseases 2020;33(2):166 View
  15. Wong Y, Ng K, Lee S. Digital health use in latent tuberculosis infection care: A systematic review. International Journal of Medical Informatics 2022;159:104687 View
  16. Shahid N, Naguit N, Jakkoju R, Laeeq S, Reghefaoui T, Zahoor H, Yook J, Rizwan M, Mohammed L. Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review. Cureus 2022 View
  17. Alvarez G, Sullivan K, Pease C, Van Dyk D, Mallick R, Taljaard M, Grimshaw J, Amaratunga K, Allen C, Brethour K, Mulpuru S, Pakhale S, Aaron S, Cameron D, Alsdurf H, Hui C, Zwerling A. Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design. International Journal of Infectious Diseases 2022;117:222 View
  18. Rangaka M, Hamada Y, Duong T, Bern H, Calvert J, Francis M, Clarke A, Ghanouni A, Layton C, Hack V, Owen-Powell E, Surey J, Sanders K, Booth H, Crook A, Griffiths C, Horne R, Kunst H, Lipman M, Mandelbaum M, White P, Zenner D, Abubakar I. Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial. BMJ Open 2022;12(9):e057717 View
  19. Kumar R, Singhal M, Kumar D, Joshi A, Islam K. Designing, Development, and Evaluation of an Informatics Platform for Enhancing Treatment Adherence in Latent Tuberculosis Infection Patients: A Study Protocol. BioMedInformatics 2023;3(1):252 View
  20. Khan A, Phares C, Phuong H, Trinh D, Phan H, Merrifield C, Le P, Lien Q, Lan S, Thoa P, Thu L, Tran T, Tran C, Platt L, Maloney S, Nhung N, Nahid P, Oeltmann J. Overseas Treatment of Latent Tuberculosis Infection in US–Bound Immigrants. Emerging Infectious Diseases 2022;28(3):582 View
  21. Pinnock H, Murphie P, Vogiatzis I, Poberezhets V. Telemedicine and virtual respiratory care in the era of COVID-19. ERJ Open Research 2022;8(3):00111-2022 View
  22. Truong C, Tanni K, Qian J. Video-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis. American Journal of Preventive Medicine 2022;62(3):450 View
  23. Alvarez G, Pease C, Menzies D. Chapter 6: Tuberculosis preventive treatment in adults. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6(sup1):77 View
  24. Danielli S, Ashrafian H, Darzi A. Healthy city: global systematic scoping review of city initiatives to improve health with policy recommendations. BMC Public Health 2023;23(1) View
  25. Alvarez G, Pease C, Menzies D. Chapitre 6: Le traitement préventif de la tuberculose chez les adultes. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2023;7(6):354 View
  26. Abas S, Ismail N, Zakaria Y, Yasin S, Ibrahim K, Ismail I, Razali A, Sherzkawi M, Ahmad N. Enhancing tuberculosis treatment adherence and motivation through gamified real-time mobile app utilization: a single-arm intervention study. BMC Public Health 2024;24(1) View
  27. Chen E, Owaisi R, Goldschmidt L, Maimets I, Daftary A. Patient perceptions of video directly observed therapy for tuberculosis: a systematic review. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2024;35:100406 View
  28. Garfein R, Liu L, Cepeda J, Graves S, San Miguel S, Antonio A, Cuevas-Mota J, Mercer V, Miller M, Catanzaro D, Rios P, Raab F, Benson C. Asynchronous Video Directly Observed Therapy to Monitor Short-Course Latent Tuberculosis Infection Treatment: Results of a Randomized Controlled Trial. Open Forum Infectious Diseases 2024;11(4) View
  29. Stoner M, Maragh-Bass A, Sukhija-Cohen A, Saberi P. Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV Research & Clinical Practice 2022;23(1):47 View
  30. Zary M, Mohamed M, Kafie C, Chilala C, Bahukudumbi S, Foster N, Gore G, Fielding K, Subbaraman R, Schwartzman K. The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review. BMJ Global Health 2024;9(7):e015633 View
  31. Sundaram K, Ahmad Zaki R, Shankar D, Hoe V, Ahmad N, Kuan W, Anhar A. Effectiveness of Video-Observed Therapy in Tuberculosis Management: A Systematic Review. Cureus 2024 View